Orion Investment Co

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 2033920 ST. LOUIS, MO

Position in IOVA

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$7,250,438

+$2,181,009 QoQ

Shares Held

2,065,652

+11.2% QoQ

Ownership

0.463%

of shares outstanding

% of Portfolio

2.35%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Orion Investment Co holds $51,893,657 across 4 Biotechnology names. IOVA ranks #3 (14.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	30,837	$23,825,899
2	IONS	Ionis Pharmaceuticals Inc	225,015	$16,896,376
3	IOVA	Iovance Biotherapeutics, Inc. This page	2,065,652	$7,250,438
4	ARWR	Arrowhead Pharmaceuticals, Inc.	62,535	$3,920,944

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,250,438	2,065,652	+11.2%	Shares	Sole	2026-05-12
2025-12-31	$5,069,429	1,856,934	+0.3%	Shares	Sole	2026-02-11
2025-09-30	$4,018,371	1,851,784	-20.8%	Shares	Sole	2025-11-13
2025-06-30	$4,022,328	2,338,563	+98.7%	Shares	Sole	2025-08-14
2025-03-31	$3,918,920	1,176,853	+10.9%	Shares	Sole	2025-05-14
2024-12-31	$7,849,587	1,060,755	+17.0%	Shares	Sole	2025-02-13
2024-09-30	$8,510,016	906,285	+14.0%	Shares	Sole	2024-11-13
2024-06-30	$6,373,494	794,700	—	Shares	Sole	2024-08-15
No filing history on record for this holder in this stock.